Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis

Background: Hydroxychloroquine (HCQ) has been used in the treatment of systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), but its effect on lupus activity during pregnancy, preeclampsia and intrauterine growth restriction (IUGR) remains unclear. Methods: PubMed, Embase and Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhengyan, Gao, Rui, Huang, Wanrong, Wang, Huiqing, Qin, Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866542/
https://www.ncbi.nlm.nih.gov/pubmed/36675415
http://dx.doi.org/10.3390/jcm12020485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866542/
https://www.ncbi.nlm.nih.gov/pubmed/36675415
http://dx.doi.org/10.3390/jcm12020485

Ejemplares similares